2016 U.K. Virology and Bacteriology Testing Market: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities

Category : Diagnostic and Biotech  | Published Date : Nov-2015 | Pages : 978

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,300.'s new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the nextfive years. The report examines key UK market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.


This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.

Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the worlds major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
reagents kits, IT and other products with significant market
appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
by individual test.

- Volume and sales forecasts for over 100 infectious disease
assays by individual test and market segment:

Blood Banks
Commercial/Private Laboratories
Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,

- Review of the market dynamics, trends,
structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
including their etiology, current diagnostic tests,
vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
testing, including their operating
characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
immunoassay,and other technologies and their potential
applications for infectious disease testing.

- Global listings of companies developing or
marketing infectious disease diagnostic products
by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
emerging market entrants, including their sales, product
portfolios, marketing tactics, collaborative
arrangements and new products in R&D.

Contains 978 pages and 159 tables

Please fill in the form below to download a TOC

* Marked Fields are Mandatory
Name * :
Email ID * :
Name of Company :
Phone No * :
Message :
Security code * :
Can't read the image? click here to refresh
Publisher Name :

Published Reports
Notes: Sales, means the sales volume of RNA In situ Hybridization Revenue, means the sales value of RNA In situ Hybridization This report studies sales (consumption) of RNA In situ Hybridization in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players ....
US $4000
Notes: Production, means the output of Sports Coaching Platforms Revenue, means the sales value of Sports Coaching Platforms This report studies Sports Coaching Platforms in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in ....
US $2900
Notes: Production, means the output of Diagnostic Imaging Revenue, means the sales value of Diagnostic Imaging This report studies Diagnostic Imaging in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export ....
US $3500

Upcoming Reports
Allergy is an exaggerated response of immune systems, which causes skin irritation, hay-fever, asthma, anaphylaxis and other symptoms. Therefore, it needs to be diagnosed and treated properly. In order to detect an allergy, skin tests and blood tests are performed by the healthcare providers .
US $ 4148
A clinical chemistry analyzer is use to analyze blood serum, plasma, urine and other body fluids with the help of various measurement technologies such as photometric and colorimetric testing, ion-selective potentiometry, and latex agglutination .
US $3390
Next Generation Sequencing (NGS) services, also known as high-throughput sequencing, is term used to describe sequencing technologies, such as Illumina sequencing, Roche 454 sequencing, and SOLiD sequencing .
US $3390
Please Select Format
Data Pack: US $ 4300
Local PDF: US $ 6700
Global User: US $ 14700

market research offer
Contact us
Call us +1-971-202-1575
--- or ---
With high quality and penned to perfection, Big Market Research is an exclusive online market to get best market research reports for your business needs and strategies. We recommend you to stop browsing as soon as you discover our website. This is because we firmly believe that once you reach here; all your business concerns will be addressed.

We have a huge collection of market research report from numerous filed which will provide you with all the necessary solution. We make sure that reports that we sell are true in context, have a quality that is unrivaled, fully integrated with equal spread of opinion. They will give you proper insights into different opportunities one may locate for their start-up pr expansion.

Let your qualms and concern be sidelined through our high end syndicated as well as customized reports.